According to Avadel Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -29.02%. At the end of 2024 the company had an Operating Margin of -29.02%.
Year | Operating Margin | Change |
---|---|---|
2024 | -29.02% | -94.95% |
2023 | -574.96% | |
2020 | -22.75% | -65.08% |
2019 | -65.16% | -40.56% |
2018 | -109.61% | -304.94% |
2017 | 53.48% | -926.91% |
2016 | -6.47% | -114.4% |
2015 | 44.91% | -107.46% |
2014 | -601.88% | -56.45% |
2013 | -1,381.98% | 999.57% |
2012 | -125.68% | 377.43% |
2011 | -26.33% | 11.4% |
2010 | -23.63% | -12.99% |
2009 | -27.16% | -9.46% |
2008 | -30.00% | -72.12% |
2007 | -107.58% | -33.64% |
2006 | -162.12% | 20.82% |
2005 | -134.18% | -899.6% |
2004 | 16.78% | -195.39% |
2003 | -17.59% | -232.04% |
2002 | 13.32% | -160.96% |
2001 | -21.85% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() | -8,391.15% | 28,815.06% | ๐บ๐ธ USA |
![]() | -1.45% | -95.00% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.